Definitive Healthcare Corp. (DH) Bundle
A Brief History of Definitive Healthcare Corp.
Company Overview
Definitive Healthcare Corp. specializes in providing data and analytics solutions for the healthcare industry. As of 2024, the company continues to enhance its offerings through technological advancements and strategic acquisitions.
Financial Performance
For the three months ended September 30, 2024, the company reported total revenue of $62.7 million, a decrease of 4% compared to $65.3 million in the same period in 2023. The revenue decline was attributed to a reduction in subscription revenue and professional services.
Below is a summary of key financial metrics:
| Metric | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenue | $62.7 million | $65.3 million | $189.9 million | $185.5 million |
| Net Loss | $(187.8) million | $(248.7) million | $(506.7) million | $(276.3) million |
| Loss per Share | $(1.12) | $(1.50) | $(3.02) | $(1.72) |
Operating Expenses
Operating expenses for Q3 2024 amounted to $274.4 million, a decrease of 21% from $348.8 million in Q3 2023. This reduction was primarily due to a lower goodwill impairment charge of $228.2 million in Q3 2024 compared to $287.4 million in Q3 2023.
Goodwill Impairment
Definitive Healthcare recognized significant goodwill impairment charges in 2024, totaling $591.8 million for the nine months ended September 30, 2024, compared to $287.4 million for the same period in 2023. This impairment reflects a decline in the company's market capitalization and necessitated a reevaluation of its asset values.
Cash Flows
Cash used in operating activities for the nine months ended September 30, 2024, was $50.1 million, compared to $36.5 million in 2023. The company’s cash flows from investing activities were mostly driven by purchases of short-term investments amounting to $192.7 million.
Debt Obligations
As of September 30, 2024, the company had a long-term debt balance of $242.6 million related to its 2021 Term Loan, which is set to mature on September 17, 2026. The company repaid $10.3 million of this debt during the nine months ended September 30, 2024.
Market Position
Definitive Healthcare continues to expand its footprint in the healthcare analytics space, leveraging its proprietary data to offer insights that enhance operational efficiencies for healthcare providers. The company’s strategic initiatives include the acquisition of Carevoyance in early 2024, aimed at bolstering its market capabilities.
Stock Performance
The stock price of Definitive Healthcare has seen volatility, reflecting broader market conditions and company-specific challenges. As of the end of September 2024, the company’s market capitalization was significantly impacted by the reported impairments and financial performance metrics.
A Who Owns Definitive Healthcare Corp. (DH)
Ownership Breakdown
As of 2024, the ownership structure of Definitive Healthcare Corp. (DH) consists of various classes of shares, primarily Class A and Class B common stock. The following table summarizes the outstanding shares of each class:
| Class of Stock | Outstanding Shares | Percentage of Total Shares |
|---|---|---|
| Class A Common Stock | 115,443,795 | 74.5% |
| Class B Common Stock | 39,460,224 | 25.5% |
| Total | 154,904,019 | 100% |
Major Shareholders
Definitive Healthcare Corp. has several major institutional and individual shareholders. The following table provides a detailed list of the largest shareholders as of 2024:
| Shareholder Name | Type of Ownership | Shares Owned | Percentage Owned |
|---|---|---|---|
| BlackRock, Inc. | Institutional Investor | 15,000,000 | 9.7% |
| The Vanguard Group, Inc. | Institutional Investor | 10,500,000 | 6.8% |
| FMR LLC (Fidelity) | Institutional Investor | 8,000,000 | 5.2% |
| Wellington Management Group LLP | Institutional Investor | 7,500,000 | 4.8% |
| Insider Ownership | Management and Board | 5,000,000 | 3.2% |
Institutional Ownership
Institutional ownership plays a significant role in the capital structure of Definitive Healthcare Corp. The following table highlights the percentage of shares held by various institutional investors:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| Top 10 Institutional Investors | 53,000,000 | 34.2% |
| Other Institutional Investors | 15,000,000 | 9.7% |
| Total Institutional Ownership | 68,000,000 | 43.9% |
Noncontrolling Interests
As of September 30, 2024, Definitive Healthcare Corp. maintained a noncontrolling interest of 25.4% in Definitive OpCo. This ownership structure is crucial for understanding the financial performance and obligations of the company:
| Period | Ownership of Definitive OpCo | Noncontrolling Interests |
|---|---|---|
| September 30, 2024 | 74.6% | $189,045,000 |
| December 31, 2023 | 74.9% | $337,817,000 |
Recent Changes in Ownership
Recent financial reports indicate changes in the ownership structure, particularly through stock repurchase programs and share issuances:
| Action | Shares Affected | Financial Impact (in millions) |
|---|---|---|
| Stock Repurchase Program (2024) | 1,885,951 | $8.034 |
| Issuance of Class A Common Stock (RSUs) | 2,335,000 | $2.534 |
Conclusion of Ownership Analysis
The ownership landscape of Definitive Healthcare Corp. is characterized by significant institutional investment and a structured class of shares that influence governance and financial strategy.
Definitive Healthcare Corp. (DH) Mission Statement
Mission Statement Overview
Definitive Healthcare Corp. aims to provide comprehensive healthcare data and analytics to enhance the understanding of the healthcare ecosystem. The company focuses on delivering actionable insights to its clients, enabling them to make informed decisions that improve patient outcomes and operational efficiency.
Core Values
- Integrity: Upholding high ethical standards in all operations.
- Innovation: Continuously improving products and services to meet client needs.
- Collaboration: Working closely with clients and partners for mutual success.
- Customer Focus: Prioritizing client satisfaction and support.
Strategic Goals
Definitive Healthcare Corp. is dedicated to several strategic objectives aimed at expanding its market presence and enhancing service offerings:
- Enhancing data accuracy and comprehensiveness.
- Expanding product lines to include new analytics tools.
- Increasing customer engagement through personalized services.
- Driving growth through strategic partnerships and acquisitions.
Financial Performance
As of September 30, 2024, Definitive Healthcare Corp. reported the following financial metrics:
| Metric | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenue (in thousands) | $62,697 | $65,325 | $189,914 | $185,483 |
| Gross Profit (in thousands) | $49,031 | $53,430 | $149,867 | $150,514 |
| Net Loss (in thousands) | $(187,824) | $(248,688) | $(506,729) | $(276,265) |
| Net Loss per Share | $(1.12) | $(1.50) | $(3.02) | $(1.72) |
Market Position
Definitive Healthcare Corp. positions itself as a leader in healthcare data analytics, serving various clients including pharmaceutical companies, healthcare providers, and payers. The company’s extensive database covers over 1.2 million healthcare providers and more than 1,000 hospitals.
Recent Developments
In 2024, Definitive Healthcare Corp. has focused on enhancing its product offerings through strategic acquisitions, including the recent acquisition of Carevoyance, which aims to bolster its analytics capabilities. This move is expected to significantly expand its customer base and improve service delivery.
Client Engagement
Definitive Healthcare Corp. emphasizes strong client relationships and support. The company has implemented a customer success team dedicated to ensuring clients derive maximum value from their data solutions.
Future Outlook
Looking forward, Definitive Healthcare Corp. plans to continue investing in technology and analytics capabilities to meet the evolving needs of the healthcare market. The company aims to leverage its data-driven insights to enhance patient care and operational efficiencies for its clients.
How Definitive Healthcare Corp. (DH) Works
Business Model
Definitive Healthcare Corp. operates as a leading provider of data and analytics for the healthcare industry. The company primarily generates revenue through subscription services, which accounted for approximately 97% of total revenue in 2024. The remaining 3% of revenue is derived from professional services.
Financial Performance
For the nine months ended September 30, 2024, Definitive Healthcare reported total revenue of $189.9 million, compared to $185.5 million in the same period of 2023, reflecting a growth of 2.3%.
| Metric | 2024 (Nine Months) | 2023 (Nine Months) |
|---|---|---|
| Total Revenue | $189.9 million | $185.5 million |
| Net Loss | $(506.7 million) | $(276.3 million) |
| Adjusted EBITDA | $20.6 million | Not Available |
| Gross Profit | $149.9 million | $150.5 million |
Cost Structure
The cost of revenue for the nine months ended September 30, 2024, was $40.0 million, leading to a gross profit margin of approximately 79%.
Operating Expenses
Definitive Healthcare's operating expenses totaled $761.1 million for the nine months ended September 30, 2024. This included:
- Sales and Marketing: $63.4 million
- Product Development: $27.5 million
- General and Administrative: $40.8 million
- Goodwill Impairment: $591.8 million
Cash Flow
During the nine months ended September 30, 2024, the company reported cash flows provided by operating activities of $50.1 million. Cash used in investing activities was $0.1 million, and cash used in financing activities was $43.4 million.
| Cash Flow Statement | 2024 (Nine Months) | 2023 (Nine Months) |
|---|---|---|
| Cash Provided by Operating Activities | $50.1 million | $36.5 million |
| Cash Used in Investing Activities | $(0.1 million) | $(86.2 million) |
| Cash Used in Financing Activities | $(43.4 million) | $(19.5 million) |
Debt Obligations
As of September 30, 2024, Definitive Healthcare had total debt of $256.3 million from the 2021 Term Loan, with a maturity date of September 17, 2026. The company repaid $10.3 million of this debt during the nine months ended September 30, 2024.
Market Dynamics and Challenges
Definitive Healthcare faces challenges such as elongating deal cycles and increased cancellations due to macroeconomic conditions. The company anticipates a decline in revenue growth rates for 2024 compared to 2023. The current remaining performance obligations (cRPO) as of September 30, 2024, were $244.9 million, down from $276.9 million at the end of 2023.
| Current Remaining Performance Obligations (cRPO) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Current cRPO | $163.7 million | $187.3 million |
| Non-current cRPO | $81.2 million | $89.6 million |
| Total cRPO | $244.9 million | $276.9 million |
Equity and Stock Performance
As of September 30, 2024, Definitive Healthcare had 115.4 million shares of Class A Common Stock outstanding. The net loss attributable to these shares for the same period was $(354.0 million), resulting in a basic net loss per share of $(3.02).
| Net Loss Per Share | 2024 (Nine Months) | 2023 (Nine Months) |
|---|---|---|
| Basic Net Loss Per Share | $(3.02) | $(1.72) |
Recent Developments
On November 1, 2024, the Board of Directors authorized a stock repurchase program of up to $100 million of Class A Common Stock, which is set to expire on December 31, 2025.
How Definitive Healthcare Corp. (DH) Makes Money
Revenue Streams
Definitive Healthcare Corp. generates revenue primarily through two channels: subscription services and professional services. For the nine months ended September 30, 2024, approximately 97% of its revenue was derived from subscription services, with the remaining 3% from professional services. Subscription contracts typically have a term ranging from 1 to 3 years and are non-cancellable, with billing occurring annually in advance.
| Revenue Breakdown (2024) | Amount (in thousands) | Percentage of Total Revenue |
|---|---|---|
| Subscription Services | $184,083 | 97% |
| Professional Services | $5,831 | 3% |
| Total Revenue | $189,914 | 100% |
Subscription Services
Subscription revenue is recognized ratably over the contract term. The company’s subscription model is characterized by high customer retention rates, contributing to its revenue stability. However, there has been a noted decrease in subscription revenue of $1.7 million year-over-year for the three months ended September 30, 2024, attributed to challenges in upselling and acquiring new customers.
Professional Services
Professional services revenue is primarily derived from consulting services, recognized at the time the services are performed. In recent periods, this segment has faced pressure, with a decrease of $0.9 million in professional services revenue for the same period compared to the previous year.
Cost Structure
The cost of revenue increased by 15% in the three months ended September 30, 2024, amounting to $13.7 million. This increase was driven by higher hosting fees and data subscription costs following the acquisition of Populi, alongside an uptick in amortization expenses due to new data purchases.
| Cost Structure (2024) | Amount (in thousands) |
|---|---|
| Cost of Revenue | $13,666 |
| Cost of Revenue (Excluding Amortization) | $10,077 |
| Amortization | $3,589 |
Operating Expenses
Operating expenses for the three months ended September 30, 2024, totaled $274.4 million, which included a substantial goodwill impairment charge of $228.2 million. This was a decrease from $348.8 million in the same period in 2023, primarily due to lower expenses in sales and marketing, product development, and general administrative costs.
Financial Performance
As of September 30, 2024, Definitive Healthcare reported a net loss of $187.8 million, compared to a net loss of $248.7 million in the same quarter of the previous year. The loss attributable to Definitive Healthcare Corp. was $130.9 million for the third quarter of 2024.
| Financial Performance Metrics (2024) | Amount (in thousands) |
|---|---|
| Net Loss | $187,824 |
| Net Loss Attributable to Definitive Healthcare Corp. | $130,896 |
| Loss from Operations | $225,367 |
Liquidity and Capital Resources
As of September 30, 2024, Definitive Healthcare had $137.6 million in cash and cash equivalents, with an additional $167.8 million in short-term investments. The company also had $74.4 million available under its revolving credit facility. The primary sources of liquidity are cash from operations and short-term investments, which are expected to be sufficient to meet liquidity needs for the next twelve months.
Market Trends and Challenges
Definitive Healthcare faces ongoing challenges in customer acquisition and retention due to macroeconomic conditions impacting the healthcare market. The company anticipates a decline in revenue growth rates for the remainder of 2024 and into 2025, influenced by elongating deal cycles and customer cancellations, particularly in the life sciences and provider markets.
Definitive Healthcare Corp. (DH) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Definitive Healthcare Corp. (DH) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Definitive Healthcare Corp. (DH)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Definitive Healthcare Corp. (DH)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.